Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Heidenreich, Falk  [Clear All Filters]
2024
Schetelig J, Baldauf H, Heidenreich F, Hoogenboom JD, Spellman SR, Kulagin A, Schroeder T, Sengeloev H, Dreger P, Forcade E, et al. Donor genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight. Front Immunol. 2024;15:1350470.
2022
Bernas SN, Behrens GA, Baldauf H, Baier DM, Fischer H, Pruschke J, Heidenreich F, Ruhner K, Hofmann JA, Markert J, et al. Reanalysis of unclear CMV status results from buccal swab samples of potential stem cell donors is an efficient donor registry strategy. Transpl Immunol. 2022:101729.
2021
Bernas SN, Baldauf H, Wendler S, Heidenreich F, Lange V, Hofmann JA, Sauter J, Schmidt AH, Schetelig J. CCR5Δ32 mutations do not determine COVID-19 disease course. Int J Infect Dis. 2021.
2018
Teipel R, Oelschlägel U, Wetzko K, Schmiedgen M, Kramer M, Rücker-Braun E, Hölig K, von Bonin M, Heidrich K, Fuchs A, et al. Differences in cellular composition of peripheral blood stem cell grafts from healthy stem cell donors mobilized with either G-CSF alone or G-CSF and Plerixafor. Biol Blood Marrow Transplant. 2018.
2016
Link CSibylle, Eugster A, Heidenreich F, Rücker-Braun E, Schmiedgen M, Oelschlägel U, Kühn D, Dietz S, Fuchs Y, Dahl A, et al. Abundant CMV reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation. Clin Exp Immunol. 2016.